Processa Pharmaceuticals, Inc. terminated its Binding Term Sheet dated June 17, 2025, on February 12, 2026, under Item 1.02. This disclosure informs investors of the end of a previously material definitive agreement.
Key takeaways
Termination of Binding Term Sheet dated June 17, 2025
Termination effective February 12, 2026
Filed under Item 1.02 Termination of a Material Definitive Agreement